Vir Biotechnology and GSK announce global expansion to Phase 3 of COMET-ICE study evaluating VIR-7831 for the treatment of COVID-19

October 6, 2020

Bay Street News

» View More News for October 06, 2020

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search

', ''); if(dynamic_styles_ids.indexOf(id) === -1) { $('style[data-ajax]').append(styles); $this.remove(); } dynamic_styles_ids.push(id); }); }; abb.modules.theme_header.init({id: 'mk-header',height: '60',stickyHeight: '40',stickyOffset: '25%',hasToolbar: 'false',}); abb.init(); -->